Fulya GÜNŞAR
Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Anabilim Dalı
Research areas: Health Sciences, Medicine, Internal Medicine Sciences, Gastroenterology and Hepatology, Internal Diseases, Surgery Medicine Sciences, Pathology, Natural Sciences, Fundamental Medical Sciences, Life Sciences
Publications
- Evaluation of Donor Exclusions for Living Donor Liver Transplantation in a Tertiary Center (2026)
- Comparison of MELD, MELD-Na, and MELD 3.0 scoring systems for transplant prioritization in the Turkish population: A multicenter study (2026)
- De Novo Malignancies after Liver Transplantation: A Multicenter Cohort Study of Incidence, Timing, and Outcomes* (2026)
- Discriminative Role of Interleukin-6, Neuropilin-1, and Amphiregulin for Cirrhosis in Patients with Chronic Hepatitis B Infection (2026)
- Liver Transplantation for Autoimmune Hepatitis: Infections are the Major Cause of Mortality (2025)
- Ornidazole-Induced Liver Injury: The Clinical Characterization of a Rare Adverse Reaction and Its Implications from a Multicenter Study (2025)
- Pre-transplant predictors of 3-Month survival following liver transplantation for acute liver failure in adult and pediatric patients in Türkiye (2025)
- The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort. (2023)
- Chanarin-Dorfman Syndrome diagnosed at the stage of liver transplantation: A rare lipid storage disease (2023)
- Diagnosis and Treatment of Autoimmune Hepatitis: Questions, Answers, and Illustrative Cases: Endorsed by Autoimmune Liver Diseases Special Interest Group, Turkish Association for the Study of Liver (2023)
- Karaciğer biyopsisi endikasyonlarında ve histopatolojik tanılarda yıllar içindeki değişim: 7 yıllık tek merkez deneyimi (2022)
- A single center experience: Liver biopsy results during a year (Liver biopsy results) (2022)
- Characteristics of patients with hepatocellular carcinoma: A multicenter study (2022)
- Ege Üniversitesi Tıp Fakültesi Hastanesi Organ Nakli Merkezi’nde Karaciğer Nakli Uygulanan Hastalarda COVID-19 ile Karşılaşma ve Aşılanma Durumlarının Değerlendirilmesi (2022)
- Eliminating Viral Hepatitis in Turkey: Achievements and Challenges (2022)
- Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome (2022)
- Ten-year single center experience in hepatotoxicity due to mushroom poisoning (2022)
- The effect of clinicopathologic findings of hepatocellular carcinoma on posttransplant survival: a multcenter cohort from TASL liver transplantation special interest group (2022)
- Trends and causes of etiology in adult liver transplant patients: multicenter study (2022)
- Karaciğer biyopsisi endikasyonlarında ve histopatolojik tanılarda yıllar içindeki değişim: 7 yıllık tek merkez deneyimi (2022)
- Ornidazol ile İlişkili Hepatotoksisite: Son 10 Yılda Hastaneye Yatırılan 24 Hastanın Değerlendirilmesi (2021)
- Kan testi parametrelerinin eklenmesi Fibroscan’ın karaciğer fibrozisini tahmin değerini arttırmamaktadır (2021)
- Determination of Turkish Norms of Psychometric Tests For Diagnosing Minimal Hepatic Encephalopathy and Proposal of a Simplified Paper Pencil Test Battery (2021)
- Outcomes of Patients with Acute Hepatotoxicity Caused by Mushroom-Induced Poisoning (2021)
- Significance of detectable hepatitis B virus DNA in liver allograft tissue in long-term follow-up of liver transplant recipients (2021)
- Predictive value of FibroScan in detecting liver fibrosis in HBeAg negative patients with chronic hepatitis B whose HBV DNA 2000-20000 IU/ml with ALT 1-2 times the upper limit of normal and those with HBV DNA >20000 IU/ml and normal ALT (2021)
- Farklı karaciğer hastalıklarında non-invaziv fibrozis göstergelerinin karaciğer biyopsisi ile uyumu ve birbirleriyle Karşılaştırılması (2021)
- Cerrahi prosedürler öncesi anti-HCV taraması: Hastalar yeterince bilgi sahibi mi? (2021)
- Steatotic and Steatohepatitic Hepatocellular Carcinomas (2021)
- Etiology of Cirrhosis in Turkey: A National Cohort Study (2021)
- Covid-19 in Liver Transplant Recipients: A National Cohort (2021)
- Infections developing in patients undergoing liver transplantation: Recipients of living donors may be more prone to bacterial/fungal infections (2021)
- Steatotic and Steatohepatitic Hepatocellular Carcinomas Features in a Series With Predominantly Viral Etiology (2021)
- Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery (2021)
- Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis (2021)
- The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists (2020)
- Nonalkolik yağlı karaciğer hastalığında histolojik progresyon ile klinik ve laboratuvar parametrelerin ilişkisi (2020)
- Infections developing in patients undergoing liver transplantation: Recipients of living donors may be more prone to bacterial/fungal infections (2020)
- KARACİĞER TRANSPLANTLI HASTALARDA HEPATİT E VİRÜS IGG SEROPREVELANSI: RETROSPEKTİF TEK MERKEZ DENEYİMİ (2020)
- Outcomes following deceased and live donor livertransplantation for the indication of acute liver failure: amulticenter experience (2020)
- Neutrophil/Monocyte Ratio: A new predictor of in hospital mortality in patients with spontaneous ascites infections (2020)
- Karaciğer, safra kesesi ve safra yolu kanserlerinde epidemiyoloji ve sağ kalım özellikleri (2019)
- Paritaprevir/Ritonavir/OmbitaSvir/Dasabuvir/Ribavirin treatment in HCV infected chronic hemodialysis patients: a single centereded experience (2019)
- The underwater part of the iceberg: Anti-HCV positivity (2019)
- Epidemiology of Hepatitis Delta Virus Infection in Izmir Turkey: A retrospective cross sectional study (2019)
- Changing in the etiologies and the presentation charactheristics in hepatocellular carcinoma. A single center experience in western Turkey (2019)
- The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir with or without Ribavirin in Patients with Hepatitis C Undergoing Chronic Haemodialysis: A Single Center Experience (2019)
- A new score based on survival-related variables in patients with decompensated cirrhosis (2019)
- Decrease in HbA1c accounts for the rapid decline in the measurement of liver stiffness by transient elastography in diabetic patients (2019)
- Karaciğer, safra kesesi ve safra yolu kanserlerinde epidemiyoloji ve sağ kalım özellikleri (2019)
- Changing patterns of upper gastrointestinal bleeding over 23 years in Turkey (2019)
- Karaciğer, safra kesesi ve safra yolu kanserlerinde epidemiyoloji ve sağ kalım özellikleri (2019)
- The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir with or without Ribavirin in Patients with Hepatitis C Undergoing Chronic Haemodialysis: A Single Center Experience (2019)
- Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort. (2019)
- Türkiye Viral Hepatit Önleme ve Kontrol Programı” “Sağlık Bakanlığı Yayın No, Ankara (2018)
- Karaciğer Nakli Yapılan Hastalarda Gelişen Enfeksiyonlar:Ege Üniversitesi Tıp Fakültesi Karaciğer Nakli KonseyiDeneyimi (2018)
- Hepatosellüler kanser etyolojisi ve prezentasyon özelliklerinde değişme: Tek merkez deneyimi (2018)
- Real world data on safety and efficacy of Ledipasvir Sofosbuvir ± RBV, Ombitasvir / Paritaprevir / Ritonavir ± Dasabuvir ± RBV combination therapy for chronic hepatitis C. A Turkey experience. (2018)
- Karaciğer Nakli Yapılan Hastalarda Gelişen Enfeksiyonlar: Ege Üniversitesi Tıp Fakültesi Karaciğer Nakli Konseyi Deneyimi (2018)
- Is telbivudine-induced polyneuropathy/myopathy reversible in liver transplant recipients? (2018)
- Genome Wide Association Study Identifies Genetic Variants Associated with Early and Sustained Response to (Peg)Interferon in Chronic Hepatitis B Patients: The GIANT-B Study (2018)
- Ege Üniversitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı’nda Son Üç Yılda Yapılmış Kolonoskopi İşlemlerinin Retrospektif İrdelenmesi (2018)
- From the Editor (2018)
- Results of 1001 liver transplantations in 23 years: Ege University experience (2018)
- Results of 1001 liver transplantations in 23 years: Ege University experience. (2018)
- LEDIPASVIR/SOFOSBUVIR THERAPY IN GENOTYPE 1 LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HCV INFECTION: SINGLE CENTER, REAL LIFE EXPERIENCE (2017)
- KRONİK HEPATİT C TEDAVİSİNDE LEDİPASVİR/SOFOSBUVİR: GERÇEK YAŞAM VERİLERİ (2017)
- ASİT VE HEPATOLOMEGALİSİ OLAN OLGUDA NADİR BİR NEDEN AA DIŞI (PRİMER) AMİLOİDOZ: OLGU SUNUMU (2017)
- KRONİK HEPATİT B NEDENİYLE KARACİĞER BİYOPSİ YAPMA ORANININ TRANSİENT ELASTOGRAFİ UYGULAMASINDAN SONRA DEĞİŞİMİ (2017)
- Kronik hepatit C tedavisinde Ledipasvir/Sofosbuvir: Gerçek yaşam verileri. (2017)
- HEMODİYALİZİN FİBROSCAN ÖLÇÜMÜNE ETKİSİ (2017)
- KARACİĞER BİYOPSİSİ VE TRANSİENT ELASTOGRAPHY (FİBROSCAN®) ARASINDAKİ UYUMLA İLİŞKİLİ FAKTÖRLER (2017)
- Böbrek Nakli Hastalarında Hepatit C Virüs Enfeksiyonunun Paritaprevir-Ritonavir-Ombitasvir-Dasavubuvir (prOD) ile Tedavisi (2017)
- KRİPTOJENİK SİROZLARDA YAŞAM SÜRESİ İLE İLİŞKİLİ PARAMETRELER (2017)
- Kronik Hepatit B Enfeksiyonlu Hastalarda Yorgunluk ve Yaşam Kalitesinin Değerlendirilmesi (2017)
- BÖBREK NAKLİHASTALARINDAKİHEPATİT C VİRUS ENFEKSİYONUNUN PARİTAPREVİR-RİTONAVİR-OMBİTASVİRDASABUVİR (PrOD) İLE TEDAVİSİ (2017)
- YAĞLI KARACİĞER HASTALIĞINDA KARACİĞER FİBROZİSİNİ DEĞERLENDİRMEDE ANLIK ELASTOGRAFİ SONUÇLARI GÜVENİLİR DEĞİLDİR (2017)
- Detectable HBVDNA in liver allograft tissues has no clinical significance on long term follow up in liver transplant recipients under HBIg plus Antiviral prophylaxis (2017)
- Is Telbivudine-Induced Polyneuropathy/Myopathy Reversible in Liver Transplant Recipients? (2017)
- HBV DNA DÜZEYİ<20000 IU/ML OLAN HEPATİT B İNFEKSİYONLU HASTALARDA ELASTOGRAFİNİN DEĞERİ (2017)
- Anti-HCV Screening before surgical procedures to protect the surgical team or to detect new treatable patients (2017)
- Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis (2017)
- Reversal of Renal Improvement After Discontinuation of Telbivudine in Liver Transplant Recipients (2016)
- KARACİĞER SİROZLU 225 HASTANIN RETROSPEKTİF TEK MERKEZLİ İRDELENMESİ (2016)
- VARİS DIŞI ÜST GASTROİNTESTİNAL KANAMALI OLGULARDA RİSK FAKTÖRLERİVE YENİ ANTİKOAGÜLANLARIN KANAMALARA ETKİSİ (2016)
- 23 YILDA VARİS DIŞI ÜST GIS KANAMALARDAKİ DEĞİŞİM TEK MERKEZ DENEYİMİ (2016)
- Karaciğer parankim hastalığı düşünülen olgularda karaciğer fibrozisinin noninvaziv tanısı ve derecelendirilmesinde ARFI tekniğinin tanısal etkinliğinin araştırılması (2016)
- Otoimmün Hepatit Tanısı Alan Hastaların Başlangıçtaki Kliniğe Yansıma Şekilleri (2015)
- Hepatosellüler Kanser Risk Skorlarının Prediktif Değeri Hastaların Tedavi Altında Olmalarından Etkilenmemektedir (2015)
- Karaciğer Transplantlı Hastalarda Telbivudin Tedavisinin Kesilmesi Sonrasında Renal Fonksiyonlardaki Değişimin Değerlendirilmesi (2015)
- HEPATOCELLULAR CARCINOMA HCC CHARACTERISTICS IN PATIENTS WITH CHRONIC HBV RELATED LIVER DISEASE (2015)
- The Predictive Values of Hepatocellular Carcinoma Risk Scores are not Affected from the Antiviral Therapy in Patients with Chronic Hepatitis B Infection (2015)
- HBV DNA 20 000IU ml ve Sürekli Normal ALT Olan Hastalarda Karaciğer Biyopsisi Sonuçları (2015)
- Tacrolimus or Mycophenylate mofetil as a second-line therapeutic options in patients with Autoimmune Hepatitis: An international multicentre observational study (2015)
- Conversion from Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients Preliminary Results of a 1 Year Study (2015)
- Alkol dışı karaciğer yağlanmalarında Fibroscan ve NAFLD fibrosis skoru karşılaştırılması (2015)
- HBV DNA 20000 IU ML ve sürekli Normal ALT olan hastalarda karaciğer biyopsi sonuçları (2015)
- Genetic Variation rs16937012 near the NCOA2 Gene Predicts Sustained Response to Interferon in Chronic Hepatitis B patients: the GIANT-B study (2015)
- Hepatit B yüzey Antijeni ve AntiHBS serolojik göstergelerinin Birlikteliği (2015)
- Close Monitoring for Polyneuropathy/Myopathy Is Warranted Among Liver Transplant Recipients on Long-Term Treatment With Telbivudine. (2014)